Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on ...

Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on ...

Scientists at the McGovern Institute for Brain Research at MIT and the Broad Institute of MIT and Harvard have re-engineered ...

Parasitic worms that infect humans are not interbreeding with those that infect cattle as previously thought. This is good ...

Gene delivery systems can target specific brain cells, a breakthrough that could lead to treatments for Parkinson's, ...

The personalized CRISPR treatment could be the future of gene therapy, but hurdles remain before everyone has access.

Readers respond to an article about gene editing and object to cuts in research funding. Also: The Covid vaccine; Senator ...

Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing ...

Qure divested for $25M, advanced AMT-130 with FDA approvals, and building infrastructure. A strong balance sheet backs ...

Researchers from The University of Osaka find that mass photometry can distinguish between full and empty rAAV particles, ...

Rocket Pharmaceuticals acknowledged the death of a patient in a pivotal trial assessing its Danon disease gene therapy candidate RP-A501, a study that the FDA has placed on clinical hold.

The custom-built gene editing treatment for 6-month-old KJ Muldoon could not have come at a more welcome or jarring time for ...